Baden-Württemberg and the United Kingdom are excellently positioned in the healthcare industry - the biotechnology, medical technology and pharmaceutical sectors - with strong clusters of innovative companies and applied research institutes.

In addition to traditional business relationships, there are numerous opportunities for cooperation in joint research and development projects. BIOPRO offers you a platform for exchanging ideas and forging new relationships with players in the UK at (networking) events.

At the same time, there are specific challenges for companies in the healthcare industry with regard to market access as a result of the UK's withdrawal from the EU. For example, a new regulatory framework for medical devices in the UK is currently being drafted and is due to come into force in July 2024 after a one-year delay.
The healthcare system in the UK - the National Health Service (NHS) - is a pioneer in terms of sustainability and has set out ambitious plans for a climate-neutral healthcare system. This target has major implications for sales of medical devices and pharmaceutical products in the UK and is increasingly influencing NHS procurement decisions. BIOPRO supports this by providing information in the form of contributions and information events.